Multi-target action of β-alanine protects cerebellar tissue from ischemic damage

Olga Kopach; Dmitri A Rusakov; Sergiy Sylantyev

doi:10.1038/s41419-022-05159-z

Multi-target action of β-alanine protects cerebellar tissue from ischemic damage

Olga Kopach, Dmitri A Rusakov, Sergiy Sylantyev

The Rowett Institute of Nutrition and Health

University College London

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

3 Downloads (Pure)

Abstract

Brain ischemic stroke is among the leading causes of death and long-term disability. New treatments that alleviate brain cell damage until blood supply is restored are urgently required. The emerging focus of anti-stroke strategies has been on blood-brain-barrier permeable drugs that exhibit multiple sites of action. Here, we combine single-cell electrophysiology with live-cell imaging to find that β-Alanine (β-Ala) protects key physiological functions of brain cells that are exposed to acute stroke-mimicking conditions in ex vivo brain preparations. β-Ala exerts its neuroprotective action through several distinct pharmacological mechanisms, none of which alone could reproduce the neuroprotective effect. Since β-Ala crosses the blood-brain barrier and is part of a normal human diet, we suggest that it has a strong potential for acute stroke treatment and facilitation of recovery.

Original language	English
Article number	747
Number of pages	11
Journal	Cell Death & Disease
Volume	13
Issue number	8
Early online date	29 Aug 2022
DOIs	https://doi.org/10.1038/s41419-022-05159-z
Publication status	Published - 29 Aug 2022

Bibliographical note

Acknowledgements
The authors are grateful to Prof. Lora Heisler (University of Aberdeen, UK) for valuable suggestions on the research strategy and to the personnel of the military unit 7420 of the Armed Forces of Ukraine for their service and support.

Funding
This study was supported by the Wellcome Trust Principal Fellowship (212251_Z_18_Z), Medical Research Council (MR/W019752/1), and European Commission NEUROTWIN grant (857562) to DR.

Keywords

Brain
Brain Injuries/drug therapy
Brain Ischemia/drug therapy
Humans
Neuroprotective Agents/pharmacology
Stroke/drug therapy
beta-Alanine/pharmacology

Access to Document

10.1038/s41419-022-05159-zLicence: CC BY

Kopach_et_al_Multi_target_Cell_Death_Disease_vor
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Final published version, 4.51 MBLicence: CC BY

Cite this

@article{368aeea23bf442ceb6956789e8df963e,

title = "Multi-target action of β-alanine protects cerebellar tissue from ischemic damage",

abstract = "Brain ischemic stroke is among the leading causes of death and long-term disability. New treatments that alleviate brain cell damage until blood supply is restored are urgently required. The emerging focus of anti-stroke strategies has been on blood-brain-barrier permeable drugs that exhibit multiple sites of action. Here, we combine single-cell electrophysiology with live-cell imaging to find that β-Alanine (β-Ala) protects key physiological functions of brain cells that are exposed to acute stroke-mimicking conditions in ex vivo brain preparations. β-Ala exerts its neuroprotective action through several distinct pharmacological mechanisms, none of which alone could reproduce the neuroprotective effect. Since β-Ala crosses the blood-brain barrier and is part of a normal human diet, we suggest that it has a strong potential for acute stroke treatment and facilitation of recovery.",

keywords = "Brain, Brain Injuries/drug therapy, Brain Ischemia/drug therapy, Humans, Neuroprotective Agents/pharmacology, Stroke/drug therapy, beta-Alanine/pharmacology",

author = "Olga Kopach and Rusakov, {Dmitri A} and Sergiy Sylantyev",

note = "Acknowledgements The authors are grateful to Prof. Lora Heisler (University of Aberdeen, UK) for valuable suggestions on the research strategy and to the personnel of the military unit 7420 of the Armed Forces of Ukraine for their service and support. Funding This study was supported by the Wellcome Trust Principal Fellowship (212251_Z_18_Z), Medical Research Council (MR/W019752/1), and European Commission NEUROTWIN grant (857562) to DR.",

year = "2022",

month = aug,

day = "29",

doi = "10.1038/s41419-022-05159-z",

language = "English",

volume = "13",

journal = "Cell Death & Disease",

issn = "2041-4889",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - Multi-target action of β-alanine protects cerebellar tissue from ischemic damage

AU - Kopach, Olga

AU - Rusakov, Dmitri A

AU - Sylantyev, Sergiy

N1 - Acknowledgements The authors are grateful to Prof. Lora Heisler (University of Aberdeen, UK) for valuable suggestions on the research strategy and to the personnel of the military unit 7420 of the Armed Forces of Ukraine for their service and support. Funding This study was supported by the Wellcome Trust Principal Fellowship (212251_Z_18_Z), Medical Research Council (MR/W019752/1), and European Commission NEUROTWIN grant (857562) to DR.

PY - 2022/8/29

Y1 - 2022/8/29

N2 - Brain ischemic stroke is among the leading causes of death and long-term disability. New treatments that alleviate brain cell damage until blood supply is restored are urgently required. The emerging focus of anti-stroke strategies has been on blood-brain-barrier permeable drugs that exhibit multiple sites of action. Here, we combine single-cell electrophysiology with live-cell imaging to find that β-Alanine (β-Ala) protects key physiological functions of brain cells that are exposed to acute stroke-mimicking conditions in ex vivo brain preparations. β-Ala exerts its neuroprotective action through several distinct pharmacological mechanisms, none of which alone could reproduce the neuroprotective effect. Since β-Ala crosses the blood-brain barrier and is part of a normal human diet, we suggest that it has a strong potential for acute stroke treatment and facilitation of recovery.

AB - Brain ischemic stroke is among the leading causes of death and long-term disability. New treatments that alleviate brain cell damage until blood supply is restored are urgently required. The emerging focus of anti-stroke strategies has been on blood-brain-barrier permeable drugs that exhibit multiple sites of action. Here, we combine single-cell electrophysiology with live-cell imaging to find that β-Alanine (β-Ala) protects key physiological functions of brain cells that are exposed to acute stroke-mimicking conditions in ex vivo brain preparations. β-Ala exerts its neuroprotective action through several distinct pharmacological mechanisms, none of which alone could reproduce the neuroprotective effect. Since β-Ala crosses the blood-brain barrier and is part of a normal human diet, we suggest that it has a strong potential for acute stroke treatment and facilitation of recovery.

KW - Brain

KW - Brain Injuries/drug therapy

KW - Brain Ischemia/drug therapy

KW - Humans

KW - Neuroprotective Agents/pharmacology

KW - Stroke/drug therapy

KW - beta-Alanine/pharmacology

UR - http://www.scopus.com/inward/record.url?scp=85136854117&partnerID=8YFLogxK

U2 - 10.1038/s41419-022-05159-z

DO - 10.1038/s41419-022-05159-z

M3 - Article

C2 - 36038575

SN - 2041-4889

VL - 13

JO - Cell Death & Disease

JF - Cell Death & Disease

IS - 8

M1 - 747

ER -

Multi-target action of β-alanine protects cerebellar tissue from ischemic damage

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this